HU58™-main-image
HU58™-image-0
HU58™-image-1
HU58™-image-2
HU58™-image-3
Start / / HU58™

HU58™

HU58™-main-image
HU58™-image-0
HU58™-image-1
HU58™-image-2
HU58™-image-3

HU58™ is a high-dose formulation of Bacillus subtilis HU58™ designed to enhance the efficacy of MegaSporeBiotic™. HU58™ can produce over 12 substances that act as natural antibiotics in the gut, thereby reducing the overgrowth of pathogenic microorganisms. Bacillus Subtilis HU58™ also produces B vitamins, vitamin K2 and an anticoagulant enzyme – nattokinase.

It is intended for anyone suffering from: gut dysbiosis, SIBO, intestinal inflammation, or histamine intolerance.

HU58™ is also recommended for frequent travellers and as a protective measure during antibiotic therapy!

What are the benefits?

  • A 40% increase in the production of short-chain fatty acids (SCFAs)
  • Support for digestion through increased production of digestive enzymes
  • Support for immune function
  • Fewer side effects of antibiotic treatment
  • Reduction in the overgrowth of pathogenic microorganisms and reduction in inflammation.
330 zł

60 capsules II This product does not contain: gluten, rice, soya, sweeteners, sugar, lactose, preservatives, anti-caking agents, colourings or flavourings.

 Dispatched within 24 hours

Poprzednia najniższa cena z ostatnich 30 dni: 330.00zł.

Description

HU58™ is a high-dose formulation of Bacillus subtilis HU58™ designed to enhance the efficacy of MegaSporeBiotic™. HU58™ can produce over 12 substances that act as natural antibiotics in the gut, thereby reducing the overgrowth of pathogenic microorganisms. Bacillus Subtilis HU58™ also produces B vitamins, vitamin K2 and an anticoagulant enzyme – nattokinase.

It is intended for anyone suffering from: intestinal dysbiosis, SIBO, inflammatory bowel conditions, or histamine intolerance. It can be taken as a preventative measure during antibiotic treatment and whilst travelling.

How HU58™ works

Bacillus subtilis HU58 is a highly potent probiotic that forms an outer protective coating known as a spore. This virtually impermeable coating protects the bacteria from harsh conditions such as heat, acid, pressure, light and the absence of oxygen. The hardy nature of Bacillus subtilis makes it an ideal probiotic that can survive production, packaging, transport and, ultimately, digestion. In fact, this species is so resilient that researchers at California Polytechnic State University reported the revival of spores from a 25-million-year-old fossil of a bee trapped in amber.

Additional information

a beautiful young woman with vitiligo

Adults and children aged 5 and over:

Week 1: 1 capsule daily with a meal

Week 2: 2 capsules daily with a meal

May be taken together with MegaSporeBiotic™

Children under 5 years of age:

Dosage to be determined by a therapist or doctor.

Do not exceed the recommended daily dose. A dietary supplement should not be used as a substitute for a varied diet and a healthy lifestyle.

Bacillus subtilis HU58™

Capsule shell: cellulose, water.

The product contains 10 billion CFU of Bacillus subtilis HU58™ bacteria.

Manufactured in the USA.

If you miss a dose, do not take a double dose of the product.

Pregnant and breastfeeding women should consult their therapist or doctor before taking this supplement.

The product can be safely stored at room temperature. The expiry date is printed on the packaging.

The pack contains 60 capsules.

Customer reviews

There are no reviews yet.

Research

MARZORATI M, ABBEELE PVD, BUBECK SS, BAYNE T, KRISHNAN K, YOUNG A, MEHTA D, DE SOUZA A.

The probiotics Bacillus subtilis HU58 and Bacillus coagulans SC208 reduced the effects of antibiotic-induced gut microbiome dysbiosis in an M-SHIME® model

Źródło: Microorganisms. 11 July 2020;8(7):1028. doi: 10.3390/microorganisms8071028. PMID: 32664604; PMCID: PMC7409217.
YOSSEF S, CLARK F, BUBECK SS, ABERNETHY J, BAYNE T, KRISHNAN K, YOUNG A.

An oral formulation of the probiotic Bacillus subtilis HU58 was safe and well tolerated in a pilot study of patients with hepatic encephalopathy

Źródło: Evidence-Based Complementary and Alternative Medicine. 30 June 2020;2020:1463108. doi: 10.1155/2020/1463108. PMID: 32714397; PMCID: PMC7345602.
CAMPBELL AW, SINATRA D, ZHANG Z, SINATRA ST

The Efficacy of Spore-Forming Bacilli Supplementation in Patients with Mild to Moderate Elevated Triglyceride Levels: A 12-week, Randomised, Double-blind, Placebo-controlled Trial

Źródło: Integr Med (Encinitas). April 2020;19(2):22–27. PMID: 33041703; PMCID: PMC7482325.
GONG Y, LI H, LI Y.

The effects of Bacillus subtilis on epithelial tight junctions in mice with inflammatory bowel disease.

Źródło: J Interferon Cytokine Res. 2016;36(2).
SAMANYA M, YAMAUCHI K.

Histological changes in the intestinal villi of chickens fed dried Bacillus subtilis var. natto.

Źródło: Comp Biochem Physiol A Mol Integr Physiol. 2002;133(1):95–104.
TAM NKM, UYEN NQ, HONG HA, et al.

The Intestinal Life Cycle of Bacillus subtilis and Its Close Relatives.

Źródło: Journal of Bacteriology. 2006;188(7):2692–2700.
MARZORATI M, ABBEELE PVD, BUBECK SS, BAYNE T, KRISHNAN K, YOUNG A, MEHTA D, DE SOUZA A.

The probiotics Bacillus subtilis HU58 and Bacillus coagulans SC208 reduced the effects of antibiotic-induced gut microbiome dysbiosis in an M-SHIME® model

Źródło: Microorganisms. 11 July 2020;8(7):1028. doi: 10.3390/microorganisms8071028. PMID: 32664604; PMCID: PMC7409217.
YOSSEF S, CLARK F, BUBECK SS, ABERNETHY J, BAYNE T, KRISHNAN K, YOUNG A.

An oral formulation of the probiotic Bacillus subtilis HU58 was safe and well tolerated in a pilot study of patients with hepatic encephalopathy

Źródło: Evidence-Based Complementary and Alternative Medicine. 30 June 2020;2020:1463108. doi: 10.1155/2020/1463108. PMID: 32714397; PMCID: PMC7345602.
CAMPBELL AW, SINATRA D, ZHANG Z, SINATRA ST

The Efficacy of Spore-Forming Bacilli Supplementation in Patients with Mild to Moderate Elevated Triglyceride Levels: A 12-week, Randomised, Double-blind, Placebo-controlled Trial

Źródło: Integr Med (Encinitas). April 2020;19(2):22–27. PMID: 33041703; PMCID: PMC7482325.
GONG Y, LI H, LI Y.

The effects of Bacillus subtilis on epithelial tight junctions in mice with inflammatory bowel disease.

Źródło: J Interferon Cytokine Res. 2016;36(2).
SAMANYA M, YAMAUCHI K.

Histological changes in the intestinal villi of chickens fed dried Bacillus subtilis var. natto.

Źródło: Comp Biochem Physiol A Mol Integr Physiol. 2002;133(1):95–104.
TAM NKM, UYEN NQ, HONG HA, et al.

The Intestinal Life Cycle of Bacillus subtilis and Its Close Relatives.

Źródło: Journal of Bacteriology. 2006;188(7):2692–2700.
front-view-female-scientist-analysing-potion-vials_23-2148571327

Customer questions (0)

There are no questions about this product yet. Log in to ask a question.